MIMS Education

Optimizing Patient Selection and Disease Management of Relapsed DLBCL Before CAR-T Cell Infusion

Optimizing Patient Selection and Disease Management of Relapsed DLBCL Before CAR-T Cell Infusion

PaediatricsInternal MedicineOncologyGeneral PracticeHaematology
A badge with ribbon in color black 0.5 Pts | An analog clock in color black 1 hour | A black calendar with white triangle in center that has a black exclamation point in the middle 27 May 2023 

Overview

About this course

Patient selection and disease management prior CAR-T therapy is the first step to success. In this video, Assistant Professor Francesca Lim, the Senior Consultant Hematologist at Singapore General Hospital, will introduce CAR-T cell therapy and share her perspective on optimized patient selection and disease management before CAR-T therapy.


Learning outcomes

  • Understand the basics of CAR-T therapy
  • Select appropriate patients for CAR-T therapy
  • Predict the response and toxicity of patients using CAR-T therapy
  • Manage patient’s disease before CAR-T therapy with appropriate washout period and bridging therapy

Topics covered

  • Basics of CAR-T therapy
  • Patient selection criteria and algorithm for CAR-T therapy
  • Predictors of response and toxicity to CAR-T therapy
  • Washout period and bridging therapy prior to CAR-T infusion

CME Point(s) Available

  • This module is accredited for 0.5 CME point for fellows of Hong Kong College of Physicians, Hong Kong College of Pathologists.
  • For fellows of Hong Kong College of Radiologist, accreditation will be processed upon completion of the application requirements. For further details, please refer to instructions listed following course enrollment.
  • Please note that this module will not earn CME credit for fellows of colleges not listed here.
  • A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CME points.

Organized by

Sponsor Logo.png